TranscripTx, Inc.
Menlo Park, CA, US· latest recorded location
TranscripTx, Inc. is named on 3 US grants and 6 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 6
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 17 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 2 | 1 |
| 2024 | 0 | 1 |
By publication year.
Technology areas
Share of 9 documents
Recent patents
- Treatment of primary ciliary dyskinesia with synthetic messenger RNA17 Oct 2023US 11,786,610 B2
- Treatment of primary ciliary dyskinesia with synthetic messenger RNA9 May 2023US 11,642,421 B2
- Treatment of primary ciliary dyskinesia with synthetic messenger RNA29 Nov 2022US 11,510,997 B2
- Treatment of primary ciliary dyskinesia with synthetic messenger rna29 Aug 2024US 2024/0285798 A1
- Treatment of primary ciliary dyskinesia with synthetic messenger rna22 Jun 2023US 2023/0190957 A1
- Treatment of primary ciliary dyskinesia with synthetic messenger rna7 Jul 2022US 2022/0211873 A1
- Treatment of primary ciliary dyskinesia with synthetic messenger rna3 Jun 2021US 2021/0162068 A1
- Treatment of primary ciliary dyskinesia with synthetic messenger rna25 Apr 2019US 2019/0117796 A1
Most cited
By later US patents